Help! Please Register

  Education &

  Good Books

  The Fungi

  Image Bank
  Lecture Bank
  Video Bank






  MIC Database

  About Us

  Our Mission
  Editorial Board
  Editorial Staff
  Legal Stuff
  Privacy Policy

This page updated:

DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy

Site built and designed for doctorfungus by Webillustrated

You are here: Education & Tools >
Enzon Pharmaceuticals, Inc.
Course and Test - take it your way
flash available

Course Title:
A New Day in Antifungal Therapy


A series of talks are given by a panel of distinguished speakers. Kieren A. Marr, MD talks on the changing epidemiology of invasive fungal disease. Thomas J. Walsh, MD talks on what is the current and future status of conventional amphotericin B. Pranatharthi H. Chandrasekar, MD talks about choosing antifungals for the right patients and the reason. Michael E. Kleinberg, MD talks on the next big thing, how can we improve?

Learning Objectives:

After participating in this activity, participants should be able to:
  1. Evaluate the currently evolving milieu, in particular the emergence of new pathogenic threats and their potential impact on patient care and treatment options.
  2. Discuss the diminishing role of conventional amphotericin B and its usefulness in the current-day environment and future treatment regimens.
  3. Determine how today's therapeutic choices can be most appropriately employed in high-risk patients.
  4. Explore methods to improve patient outcomes, considering antifungal efficacy, safety, and cost-effectiveness.

Faculty Biographies & Disclosures:

John R. Perfect, MD
Pranatharthi H. Chandrasekar, MD
Michael E. Kleinberg, MD, Ph.D.
Kieren A. Marr, MD
Thomas J. Walsh, MD


Accreditation Statement:

ArcMesa Educators is accredited by the Accreditation Council for Continuing Medical Education (ACCNE #0006174) to provide continuing medical education for physicians.

ArcMesa Educators designates this educational activity for a maximum of 2.5 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity. This program expires January 31, 2006.


Commercial Support Statement:

This program is supported by an unrestricted educational grant from Enzon Pharmaceuticals, Inc.

Computer Software/Hardware Requirements:

The Doctorfungus CME center requires Microsoft's Internet Explorer and/or Netscape's Navigator browser version 4.x or higher. The latest browsers version are recommend.

In an attempt to bring you the greatest level of interactivity and usability, Doctorfungus uses leading edge web technologies that can result in inoperability of certain CME activities if your computer is not equipped with the most recent browser version.

Depending upon your computers current configuration, the CME activities presented may require additional software - or plug-ins - to view multimedia presentation or printable versions of their content.

This software, which may already installed on your computer, will likely be one or more of the following: Macromedia Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.

Hardware requirements are a PC or Mac with internet connectivity. For audio enhanced activities you will need a sound card and speakers.


Privacy Policy
Site Contents Copyright © 2007


  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us's sponsors